Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Similar documents
Multi-Drug Resistant Organisms (MDRO)

Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Horizontal vs Vertical Infection Control Strategies

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Preventing Clostridium difficile Infection (CDI)

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Multidrug Resistant Organisms (MDROs) and Clostridium difficile (C. diff)

Other Enterobacteriaceae

APIC CHAPTER PRESENTATION 7/2014

Surveillance of Multi-Drug Resistant Organisms

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Infection Control & Prevention

Clostridium Difficile Primer: Disease, Risk, & Mitigation

What bugs are keeping YOU up at night?

Carbapenemase-Producing Enterobacteriaceae (CPE)

Overview of C. difficile infections. Kurt B. Stevenson, MD MPH Professor Division of Infectious Diseases

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Infection Control of Emerging Diseases

Keeping Antibiotics Working: Nursing Leadership in Action

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Antimicrobial stewardship: Quick, don t just do something! Stand there!

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

Antibiotic Stewardship in LTC What does this mean?

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 2 Understanding the spread

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Presented by: Mary McGoldrick, MS, RN, CRNI

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Antibiotic stewardship in long term care

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

Control of Multidrug-resistant Organisms in a Hospital Environment: Multidimensional Approach

Get Smart For Healthcare

Clostridium difficile Infection Prevention. Basics of Infection Prevention 2-Day Mini-Course 2012

Infection Prevention & Control: PPE and Beyond. Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Public Health Response to Emerging Resistance

Antimicrobial Resistance. The Case for Diagnostics to Better Direct Therapy

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

Two (II) Upon signature

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

MDRO: Prevention in 7 Steps. Jeanette Harris MS, MSM, MT(ASCP), CIC MultiCare Health System Tacoma, Wa.

Dissecting the epidemiology of resistant Enterobacteriaceae and non-fermenters

Overview of Infection Control and Prevention

Antibiotic Stewardship in the Hospital Setting

Testimony of the Natural Resources Defense Council on Senate Bill 785

Infection Control Priorities for Antibiotics Resistance - The Search and Destroy Strategy. WH Seto Hong Kong China

Chasing Zero Infections Coaching Call Don t Be Resistant: Reducing MRSA and Other Multi-Drug Resistant Organisms May 8, 2018

Using Web-Based Instruction Modules to Improve Practitioner Knowledge at Yale New Haven Hospital on the Prevention of Antimicrobial Resistance and

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP

Clostridium difficile Colitis

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

MRSA Outbreak in Firefighters

Infection control: Need for robust guidelines

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea

Nosocomial Antibiotic Resistant Organisms

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Collecting and Interpreting Stewardship Data: Breakout Session

Policy Forum. Environmental and Professional Hygiene: Toward the Prevention of Drug Resistant Infections

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Nosocomial Infections: What Are the Unmet Needs

(DRAFT) RECOMMENDATIONS FOR THE CONTROL OF MULTI-DRUG RESISTANT GRAM-NEGATIVES: CARBAPENEM RESISTANT ENTEROBACTERIACEAE

MICRO-ORGANISMS by COMPANY PROFILE

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

So Why All the Fuss About Hand Hygiene?

Is biocide resistance already a clinical problem?

Antimicrobial Cycling. Donald E Low University of Toronto

Infection Prevention and Control Policy

Antimicrobial stewardship in companion animals: Welcome to a whole new era

Version Control Sheet

Approval Signature: Original signed by Dr. Michel Tetreault Date of Approval: July Review Date: July 2017

Epidemiology and Economics of Antibiotic Resistance

Appropriate antimicrobial therapy in HAP: What does this mean?

Summary of the latest data on antibiotic resistance in the European Union

What s next in the antibiotic pipeline?

Appropriate Antimicrobial Use in California: The Path of Least Resistance

Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S

Using Data to Track Antibiotic Use and Outcomes

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Enterococcal Species

New Drugs for Bad Bugs- Statewide Antibiogram

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Recommendations for Prevention and Control of Methicillin- Resistant Staphylococcus aureus (MRSA) in Acute Care Facilities

11/2/2015. Update on the Treatment of Clostridium difficile Infections. Disclosure. Objectives

Screening programmes for Hospital Acquired Infections

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

The Rise of Antibiotic Resistance: Is It Too Late?

Infection Prevention & Control in Ambulatory Surgical Centers. Objectives

Hospital Acquired Infections. Anucha Apisarnthanarak, MD Infectious Disease Division Thammasart University Hospital

Transcription:

Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal 07.03.01 2009

Methicillin Resistant Staphlococcus aureus (MRSA) About 3-8% of the population at large is a carrier of MRSA with no apparent ill effect. MRSA-colonized and infected patients readily contaminate their environment, and healthcare personnel coming into contact with patients or their environment readily become contaminated. Infect Control Hosp Epidemiol 2008;29:S62 S80 2008 by The Society for Healthcare Epidemiology of America.

Transmission MRSA can live for hours, up to days on surfaces such as cotton and polyester (our scrubs for instance). It spreads most commonly on HCW s hands.

MRSA Prevention Contact Precautions for patients who are infected or colonized with MRSA. Hand hygiene preferably with hand sanitizer Handouts for patients and their families are available. Surveillance to monitor and measure control efforts Judicious use of antibiotics Siegel, Jane MD, and the Healthcare Infection Control Practices Advisory Committee. Management of Multidrug- Resistant Organisms In Healthcare Settings, 2006

MRSA Prevention cont d: We identify patients who have had MRSA previously cultured. Patients that are identified will be automatically placed on Contact Precautions and screened to determine the need for continued Contact Precautions.

Vancomycin Resistant Enterococcus (VRE) Enterococcus resides in our intestines as normal flora. It concerns us when it develops resistance to Vancomycin. It has the potential to cause urinary tract infection, bloodstream infection or surgical site infection.

VRE Transmission: VRE can live for hours, up to days on surfaces such as cotton and polyester (scrubs and privacy curtains for instance). It can be carried on our hands or contaminated equipment. 1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Ifnectious Agents in Healthcare Settings, June 2007 http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf

VRE Prevention: Contact Precautions for patients who are infected or colonized with VRE. Hand hygiene preferably with hand sanitizer Handouts for patients and their families are available. Surveillance to monitor and measure control efforts 1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007 Guideline for Isolation Precautions: Preventing Transmission of Ifnectious Agents in Healthcare Settings, June 2007 http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf

VRE Prevention cont d: Processes identify patients who have had VRE previously cultured and this flags the patient on subsequent admissions to be screened. To screen a patient for VRE a rectal swab or stool sample must be obtained. Judicious antibiotic use Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1995;44(No. RR-12):

Clostridium difficile (C.diff): C.diff is a bacteria that causes the most common infectious healthcare-associated gastrointestinal illness.¹ 1 Dubberke E, ICHE 2009 30:57-66

C. diff Associated Disease Usually presents with diarrhea, but may occur without diarrhea and mimic other abdominal syndromes. Complications (shock, colectomy, perforation, megacolon, death) developed in 11% with first recurrence¹ 20% may have recurrent diarrhea after resolution of the initial episode² 1. Pepin J, et al. Clin Infect Dis. 2005;40:1591-1597. 2. McFarland LV, etal. AM J Gastroentero 2002;97:1769-1775.

C.diff Transmission: C. diff can form into a spore, which makes it very hardy and difficult to kill. It can live for months in the environment. Hands or equipment come in contact with the spores that are then carried to the patient who becomes colonized with it in their gut. If the patient then is exposed to antibiotics, chemotherapy, or gastrointestinal surgery they are at risk for developing a C.diff infection w/ toxin production, especially older patients. 1. Carrico,Ruth PhD, RN, CIC. Guide to the Elimination of Clostridium difficile in Healthcare Settings, Assoc. for Professionals in Inf Cont and Epidem, 2008.

Changing Epidemiology Recent statistics show a doubling of hospital discharges in the U.S. w/ C.diff listed as a diagnosis Also increasing severity of complications and mortality related to C.diff 1. Carrico,Ruth PhD, RN, CIC. Guide to the Elimination of Clostridium difficile in Healthcare Settings, Assoc. for Professionals in Inf Cont and Epidem, 2008.

C. diff Prevention Contact Precautions for infected patients for the duration of their admission: 1. Private room 2. Limit movement out of the patient s room 3. Dedicated patient care equipment 4. Wear gloves when entering the patients room and a gown if contact with the bed is anticipated

C.diff Prevention cont d: Ensure cleaning and disinfection of equipment and the environment. Bleach is currently the only FDA approved disinfectant. Educate patients and their families/visitors Measure compliance of hand hygiene and isolation precautions Soap and water hand hygiene is most effective method Judicious use of antibiotics

Other MDROs Gram-negative bacteria to include: Resistant Acinetobacter species ESBLs = extended-spectrum β-lactamase producing organism Resistant Pseudomonas aeruginosa CRE/KPC = Carbapenem Resistant Enterobacteriaceae /Klebsiella pneumoniae carbapenemase producing organism

Diagnose & Treat Infections Effectively Target the Pathogen Culture the patient Target empiric therapy to likely pathogens and local antibiogram Target definitive therapy to known pathogens and antimicrobial susceptibility test results Access the experts Consult ID experts for patients with serious infections The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Prevent Infection Vaccinate Give influenza/ pneumococcal vaccine to at risk patients before discharge Get the catheters out Use catheters only when essential Use correct catheter Use proper insertion & catheter-care protocols Remove catheters when no longer essential The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Use Antimicrobials Wisely Practice antimicrobial control Engage in local antimicrobial control efforts Use local data Know your antibiogram Know your patient population The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Use Antimicrobials Wisely Treat infection, not colonization Use proper antisepsis for blood and other cultures Culture the blood, not the skin or catheter hub Use proper methods to obtain & process all cultures Treat pneumonia, not tracheal aspirate Treat bacteremia, not catheter tip or hub Treat urinary tract infection, not the catheter The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Use Antimicrobials Wisely Stop antimicrobial treatment When the infection is cured When cultures are negative & infection is unlikely When infection is not diagnosed The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Prevent Transmission Isolate the pathogen Use standard infection control precautions Contain infectious body fluids (Follow airborne, droplet and contact precautions) When in doubt consult infection control experts Break the chain of contagion Stay home when you are sick Keep your hands clean Set the example The Campaign to Prevent Antimicrobial Resistance in Healthcare Settings CDC Foundation with support from Pharmacia, the Sally S. Potter Endowment Fund, and Premier

Appropriate Antimicrobial Stewardship Optimal choice of antibiotic Dose Duration of treatment Control of antibiotic use Prevents or slows the emergence of resistance among microorganisms